A recently published, unexpected discovery coming from researchers at Albert Einstein College of Medicine at Yeshiva University suggests that vitamin C may be a useful component to treating drug-resistant tuberculosis. This finding may sound more like something out of a television medical drama than real life, but the research—funded by the National Institute for Allergy and Infectious Disease at the National Institutes of Health—suggests that ascorbic acid may help kill the bacteria that cause TB.
These preliminary findings have laid a foundation for clinical trials using vitamin C in tandem with other drugs. Researchers observed that vitamin C treatment of the cultured bacteria led to generation of harmful “free radicals” in both drug-sensitive and drug-resistant TB strains. It remains to be seen if vitamin C can have the same effect on the bacteria that have infected a human. Multi- and extreme-drug resistant forms of TB (MDR- and XDR-TB) are significant health threats and developing effective therapy requires the research community using every tool available. Continue reading →